Market Access Issues Hindering Specialists’ Use of Advanced Systemics in Lupus Nephritis
27 juil. 2023 16h00 HE
|
Spherix Global Insights
Exton, Pennsylvania, July 27, 2023 (GLOBE NEWSWIRE) -- While the approvals of GSK’s Benlysta (belimumab) and Aurinia’s Lupkynis (voclosporin) have provided rheumatologists and nephrologists with...
[Latest] Global Women’s Health Diagnostics Market Size/Share Worth USD 45.4 Billion by 2032 at a 7.6% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
18 juil. 2023 04h30 HE
|
Custom Market Insights
Austin, TX, USA, July 18, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Women’s Health Diagnostics Market Size, Trends and Insights By Application...
[Latest] Global Water Treatment Equipment Market Size/Share Worth USD 96.7 Billion by 2032 at a 6.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
14 juil. 2023 13h30 HE
|
Custom Market Insights
Austin, TX, USA, July 14, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Water Treatment Equipment Market Size, Trends and Insights By Type (Process...
Incannex Announces Intention to Redomicile to United States, List all Shares on Nasdaq
10 juil. 2023 07h30 HE
|
Incannex Healthcare
Highlights: Incannex to redomicile to the United States via a Scheme of Arrangement pursuant to Australian lawA newly formed Delaware corporation (Incannex Healthcare Inc.) will become the ultimate...
IGadgets Collaborates with Lumaflex to Market the World's First Portable, Waterproof, Flexible Red Light Therapy Device
06 juil. 2023 07h57 HE
|
IGadgets
GARDEN GROVE, Calif., July 06, 2023 (GLOBE NEWSWIRE) -- IGadgets announces a collaboration with Lumaflex, the creator of the world's first portable, waterproof red light therapy device. IGadgets has...
GRI Bio (NASDAQ: GRI) Bolsters Patent Portfolio
27 juin 2023 08h45 HE
|
GRI Bio, Inc.
- U.S. patent issuance for lead program, GRI-0621, in development for the treatment of idiopathic pulmonary fibrosis (IPF) - Company building a robust global patent estate LA JOLLA, CA, June...
Dimensions Announces Ground-breaking Therapeutic Program for Veterans
07 juin 2023 10h00 HE
|
Dimensions Health Centres
TORONTO, June 07, 2023 (GLOBE NEWSWIRE) -- Dimensions, has announced that Veterans Affairs Canada (VAC) has officially approved their ELEVATE for Veterans-Only Program as a VAC Interdisciplinary...
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Award for Novel Cancer Immunotherapy Treatment, Granted for Prostate Cancer, Colon Cancer, Ovarian Cancer, Kidney Cancer, Breast Cancer, Glioblastoma, Melanoma, and Lung Cancer.
23 mai 2023 08h01 HE
|
Ocean Biomedical, Inc.
Latest patent broadens protection around OCEA’s platform of first-in-class anti-CHi3L1 therapeutic immunotherapy candidates, based on the breakthrough discovery by scientific co-founder, Dr. Jack A....
GRI Bio (NASDAQ: GRI) Provides Business Outlook and Highlights Upcoming Milestones for Innovative Pipeline of NKT Cell Modulators
22 mai 2023 08h45 HE
|
GRI Bio, Inc.
Rapidly advancing clinical pipeline in potential high-value inflammatory, fibrotic and autoimmune diseases Leading NKT regulation technology targeting earlier in the inflammatory cascade to...
Mount Sinai Brooklyn Expands Cancer Services, Infusion Center in $4 Million Project
19 mai 2023 14h20 HE
|
Mount Sinai Health System
NEW YORK, May 19, 2023 (GLOBE NEWSWIRE) -- The Mount Sinai Health System today held a grand opening of the expansion of the Mount Sinai Brooklyn Ambulatory Infusion Center, a cancer treatment center...